Product Document Searching Made Easy by 2D Code! | TCI Chemistry News July 2026 | [Product Highlights] Chain Transfer Agents for Cationic RAFT... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
CAS RN: 56796-39-5 | Product Number: C3029
Cefmetazole Sodium Salt
Purity: >92.0%(HPLC)
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
Supplemental Product Information:
This product has not been tested for potency and is guaranteed for chemical purity.
| Product Number | C3029 |
Purity / Analysis Method
|
>92.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__5H__1__6N__7NaO__5S__3 = 493.51 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Hygroscopic |
Packaging and Container
|
1G-Glass Bottle with Plastic Insert (View image), 250MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 56796-39-5 |
Related CAS RN
|
56796-20-4 |
| Reaxys Registry Number | 5403925 |
| PubChem Substance ID | 253660567 |
| Merck Index (14) | 1926 |
| MDL Number | MFCD00214260 |
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 92.0 area% |
| Purity(Ion exchange titration) | min. 97.0 % |
| Specific rotation [a]20/D | +73.0 to +85.0 deg(C=1, H2O) |
| NMR | confirm to structure |
| Specific Rotation | 80° (C=1,H2O) |
| Solubility (soluble in) | Acetone |
| Solubility (insoluble in) | Chloroform, Tetrahydrofuran |
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
| Precautionary Statements | P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. |
| RTECS# | XI0372200 |
| H.S.code* | 2941.90-000 |
References
- Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus
- Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
- Enhanced rectal absorption of cefmetazole and cefoxitin in the presence of epinephrine metabolites in rats and a high-performance liquid chromatographic assay for cephamycin antibiotics
- Review of the in-vitro spectrum and characteristics of cefmetazole (CS-1170)
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.